ANIX

Anixa Biosciences Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 5/10
  • Momentum 3/10
Anixa Biosciences sales and earnings growth
ANIX Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 12.82%
  • FCF Y/Y 2.21%
Anixa Biosciences gross and profit margin trends
ANIX Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -76.90%
Anixa Biosciences net debt vs free cash flow
ANIX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Anixa Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗